skip to main content
Idioma:
Resultados 1 2 3 4 5 next page
Refinado por: tipo de recurso: Imagens remover
Result Number Material Type Add to My Shelf Action Record Details and Options
1
Schematic representation of the descriptive dependences of the interpretable predictions of sensitivity to active anti-cancer molecular forms of transcriptomal cell lines inherent in tumors | Interpretable prognosis for susceptibility to active anti-cancer molecular forms, based on amides/carboxylic acids - hydrolysis derivatives of natural nitrile glycosides, of transcriptome cell lines inherent in tumors
Schematic representation of the descriptive dependences of the interpretable predictions of sensitivity to active anti-cancer molecular forms of transcriptomal cell lines inherent in tumors | Interpretable prognosis for susceptibility to active anti-cancer molecular forms, based on amides/carboxylic acids - hydrolysis derivatives of natural nitrile glycosides, of transcriptome cell lines inherent in tumors
Material Type:
Imagem 		Adicionar ao Meu Espaço

Schematic representation of the descriptive dependences of the interpretable predictions of sensitivity to active anti-cancer molecular forms of transcriptomal cell lines inherent in tumors | Interpretable prognosis for susceptibility to active anti-cancer molecular forms, based on amides/carboxylic acids - hydrolysis derivatives of natural nitrile glycosides, of transcriptome cell lines inherent in tumors

Tsanov, Vasil

figshare 2023

Texto completo disponível

Citações Citado por
2
De-novo and acquired resistance to immune checkpoint targeting (Figure 4)
De-novo and acquired resistance to immune checkpoint targeting (Figure 4)
Material Type:
Imagem 		Adicionar ao Meu Espaço

De-novo and acquired resistance to immune checkpoint targeting (Figure 4)

Syn, Nicholas

figshare 2017

Texto completo disponível

Citações Citado por
3
The Lancet Oncology: De-novo and acquired resistance to immune checkpoint targeting (Figure 3)
The Lancet Oncology: De-novo and acquired resistance to immune checkpoint targeting (Figure 3)
Material Type:
Imagem 		Adicionar ao Meu Espaço

The Lancet Oncology: De-novo and acquired resistance to immune checkpoint targeting (Figure 3)

Syn, Nicholas

figshare 2017

Texto completo disponível

Citações Citado por
4
Hallmarks of Cancer Immunoresistance (The Lancet Oncology review article: De-novo and acquired resistance to immune checkpoint targeting. 2017;18:e731–e741)
Hallmarks of Cancer Immunoresistance (The Lancet Oncology review article: De-novo and acquired resistance to immune checkpoint targeting. 2017;18:e731–e741)
Material Type:
Imagem 		Adicionar ao Meu Espaço

Hallmarks of Cancer Immunoresistance (The Lancet Oncology review article: De-novo and acquired resistance to immune checkpoint targeting. 2017;18:e731–e741)

Syn, Nicholas

figshare 2017

Texto completo disponível

Citações Citado por
5
BMP Signaling Pathway_Aravind Reddy Tarugu
BMP Signaling Pathway_Aravind Reddy Tarugu
Material Type:
Imagem 		Adicionar ao Meu Espaço

BMP Signaling Pathway_Aravind Reddy Tarugu

Tarugu, Aravind Reddy

figshare 2022

Texto completo disponível

Citações Citado por
6
Supplemental Figure S4
Supplemental Figure S4
Material Type:
Imagem 		Adicionar ao Meu Espaço

Supplemental Figure S4

Paulukinas, Ryan ; Mesaros, Clementina A. ; Penning, Trevor M.

figshare 2022

Texto completo disponível

Citações Citado por
7
Supplemental Figure S2
Supplemental Figure S2
Material Type:
Imagem 		Adicionar ao Meu Espaço

Supplemental Figure S2

Paulukinas, Ryan ; Mesaros, Clementina A. ; Penning, Trevor M.

figshare 2022

Texto completo disponível

Citações Citado por
8
Supplemental Figure S1.pdf
Supplemental Figure S1.pdf
Material Type:
Imagem 		Adicionar ao Meu Espaço

Supplemental Figure S1.pdf

Paulukinas, Ryan ; Mesaros, Clementina A. ; Penning, Trevor M.

figshare 2022

Texto completo disponível

Citações Citado por
9
Supplemental Figure S3
Supplemental Figure S3
Material Type:
Imagem 		Adicionar ao Meu Espaço

Supplemental Figure S3

Paulukinas, Ryan ; Mesaros, Clementina A. ; Penning, Trevor M.

figshare 2022

Texto completo disponível

Citações Citado por
10
De-novo and acquired resistance to immune checkpoint targeting (The Lancet Oncology)
De-novo and acquired resistance to immune checkpoint targeting (The Lancet Oncology)
Material Type:
Imagem 		Adicionar ao Meu Espaço

De-novo and acquired resistance to immune checkpoint targeting (The Lancet Oncology)

Syn, Nicholas

figshare 2017

Texto completo disponível

Citações Citado por
Resultados 1 2 3 4 5 next page

  • Realização: ABCD-USP USP   Logos de Redes Sociais: Freepik

Buscando em bases de dados remotas. Favor aguardar.